Yahoo
    Canadian Sec - Delayed Quote CAD

    Vext Science, Inc. (VEXT.CN)

    0.2400 -0.0050 (-2.04%)
    At close: November 3 at 2:56:58 PM EST
    VEXT.CN Q3 2026 earnings call
    Replay the call for the latest insights.
    Read transcript
    Chart Range Bar
    Advanced Chart
    AlphaSpace Chart
    Loading chart for VEXT.CN
    • Previous Close 0.2450
    • Open 0.0000
    • Bid --
    • Ask --
    • Day's Range 0.0000 - 0.0000
    • 52 Week Range 0.0000 - 0.4000
    • Volume 0
    • Avg. Volume 61,560
    • Market Cap (intraday) 59.45M
    • Beta (5Y Monthly) 0.93
    • PE Ratio (TTM) --
    • EPS (TTM) -0.0800
    • Earnings Date Nov 3, 2026
    • Forward Dividend & Yield -- (0.00%)
    • Ex-Dividend Date --
    • 1y Target Est 0.95

    Vext Science, Inc., through its subsidiaries, engages in integrated cannabis operations in the United States. It owns and manages cultivation facilities, manufacturing units, and dispensaries; and involves in the cultivation, extraction, manufacture, and sale of THC and CBD cartridges, concentrates, edibles, and extracts. The company also engages in the retail dispensary activities; and wholesale distribution of cannabis THC and hemp CBD products under the Vapen, Pure Touch, Appalachian Pharm, Herbal Wellness, Prism, Firebrand, and Revibe brands. The company was formerly known as Vapen MJ Ventures Corporation and changed its name to Vext Science, Inc. in November 2019. Vext Science, Inc. was incorporated in 2015 and is headquartered in Phoenix, Arizona.

    vextscience.com

    --

    Full Time Employees

    December 31

    Fiscal Year Ends

    Healthcare

    Sector

    Drug Manufacturers - Specialty & Generic

    Industry

    More about Vext Science, Inc.

    Recent News

    View More
    View More

    Performance Overview

    Trailing total returns as of 11/3/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

    YTD Return

    VEXT.CN
    4.00%
    S&P/TSX Composite index (^GSPTSE)
    11.50%

    1-Year Return

    VEXT.CN
    14.29%
    S&P/TSX Composite index (^GSPTSE)
    17.42%

    3-Year Return

    VEXT.CN
    17.24%
    S&P/TSX Composite index (^GSPTSE)
    79.23%

    5-Year Return

    VEXT.CN
    69.62%
    S&P/TSX Composite index (^GSPTSE)
    67.09%

    Earnings Trends

    View More

    Earnings Per Share (GAAP)

    Revenue vs. Earnings

    Annual
    Quarterly
    Annual
    Quarterly
    Q3 FY26
    Revenue 14.9M
    Earnings -4.88M
    Profit Margin -32.78%

    Q4

    FY25

    Q1

    FY26

    Q2

    FY26

    Q3

    FY26

    -10M
    -5M
    0
    5M
    10M
    -60.0%
    -40.0%
    -20.0%
    View More

    Analyst Insights

    View More

    Analyst Price Targets

    0.95
    0.95 Average
    0.2400 Current
    0.95 High

    Analyst Recommendations

    • Strong Buy
    • Buy
    • Hold
    • Underperform
    • Sell
    View More

    Statistics

    View More

    Valuation Measures

    Annual
    As of 10/30/2026

    • Market Cap

      60.69M

    • Enterprise Value

      102.23M

    • Trailing P/E

      --

    • Forward P/E

      --

    • PEG Ratio (current)

      --

    • Price/Sales (ttm)

      0.87

    • Price/Book (mrq)

      0.79

    • Enterprise Value/Revenue

      1.46

    • Enterprise Value/EBITDA

      9.59

    Financial Highlights

    Profitability and Income Statement

    • Profit Margin

      -28.39%

    • Return on Assets (ttm)

      -1.82%

    • Return on Equity (ttm)

      -22.98%

    • Revenue (ttm)

      50.68M

    • Net Income Avi to Common (ttm)

      -14.39M

    • Diluted EPS (ttm)

      -0.0800

    Balance Sheet and Cash Flow

    • Total Cash (mrq)

      4.54M

    • Total Debt/Equity (mrq)

      62.33%

    • Levered Free Cash Flow (ttm)

      1.94M

    View More

    Compare

    Compare

    Select to analyze similar companies using key performance metrics; select up to 4 stocks.

    VEXT.CN
    Vext Science, Inc.
    0.2400
    -2.04%
    Mkt Cap CAD 59.45M
    Industry Drug Manufacturers—Specialty & Generic
    GRIN.CN
    Grown Rogue International Inc.
    0.5100
    0.00%
    Mkt Cap CAD 127.469M
    Industry Drug Manufacturers—Specialty & Generic
    MUSH.V
    Mercanto Holdings Inc.
    0.1100
    0.00%
    Mkt Cap CAD 5.684M
    Industry Drug Manufacturers—Specialty & Generic
    MRMD.CN
    MariMed Inc.
    0.0650
    -7.14%
    Mkt Cap CAD 26.243M
    Industry Drug Manufacturers—Specialty & Generic
    AUSAF
    Australis Capital Inc.
    0.0000
    0.00%
    Mkt Cap 2,782
    Industry Drug Manufacturers—Specialty & Generic
    CBST.NE
    Mkt Cap undefined -
    Industry -
    IAN.CN
    iAnthus Capital Holdings, Inc.
    0.0050
    0.00%
    Mkt Cap CAD 34.874M
    Industry Drug Manufacturers—Specialty & Generic
    RWB.CN
    Red White & Bloom Brands Inc.
    0.0200
    0.00%
    Mkt Cap CAD 9.412M
    Industry Drug Manufacturers—Specialty & Generic
    DB.V
    Decibel Cannabis Company Inc.
    1.8000
    0.00%
    Mkt Cap CAD 1.039B
    Industry Drug Manufacturers—Specialty & Generic
    PLTH.CN
    Planet 13 Holdings Inc.
    0.1100
    +4.76%
    Mkt Cap CAD 36.885M
    Industry Drug Manufacturers—Specialty & Generic
    LEEF.CN
    Leef Brands Inc.
    0.2150
    +4.88%
    Mkt Cap CAD 65.695M
    Industry Drug Manufacturers—Specialty & Generic

    People Also Watch

    JUSH.CN Jushi Holdings Inc.
    0.7200 +2.86%
    CL.CN Cresco Labs Inc.
    0.8800 +10.00%
    RWB.CN Red White & Bloom Brands Inc.
    0.0200 0.00%
    FNT-U.CN FLUENT Corp.
    0.0150 -25.00%
    VIBE.CN Vibe Growth Corporation
    0.6300 0.00%
    Mobilize your Website
    View Site in Mobile | Classic
    Share by: